The Influence of Prescribed Exercise on Pain Related Fear Following Concussion in Collegiate Athletes
Launched by UNIVERSITY OF VIRGINIA · Jan 29, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different levels of aerobic exercise can affect recovery from a concussion in college athletes. Researchers want to find out if doing light or moderate exercise, like walking on a treadmill, can help reduce feelings of pain-related fear, anxiety, and depression, as well as how quickly athletes feel better after their concussion. Participants will start exercising two days after their concussion diagnosis and will exercise five times a week until they no longer have symptoms.
To participate, you need to be a college athlete who is currently experiencing concussion symptoms. However, if you've had serious brain injuries in the past or certain health conditions that prevent you from exercising, you won't be eligible. Throughout the trial, participants will be randomly assigned to either the light or moderate exercise group, allowing researchers to compare how the level of exercise impacts recovery. This study is important because it could help improve recovery strategies for athletes who suffer concussions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Collegiate athlete (varsity)
- • Symptomatic at time of exercise prescription
- Exclusion Criteria:
- • If advanced neuroimaging was performed, any subject with a structural abnormality will be excluded
- • History of traumatic brain injury requiring hospitalization
- • Not cleared to play their sport by a physician due to some other injury such as an ankle sprain or muscle strain
- • If individual is diagnosed with any condition that is a contraindication to aerobic exercise. Please note that all participants will have already been cleared to participate in their respective collegiate sport after extensive pre-participation physical examinations upon entering the university.
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported